explore -WSS

explore

author：comprehensive 2025-10-01 23:58:37 - browse：73774

Chemotherapy infusion — The White House outlined its efforts to end shortages of three key generic chemotherapies. But experts want more more details. Gerry Broome/AP

WASHINGTON — The White House says it’s working to end shortages of three key generic chemotherapies. But experts said the administration would have to provide more details to fully mitigate the health care system’s concerns.

Carboplatin, cisplatin, and methotrexate are three of 15 cancer drugs in shortage in the United States. They have been staples of cancer treatment for decades, according to a White House blog post, but their supply in the United States has been nearly halved in the past year. The shortages have forced doctors to ration the drugs and alter treatment plans, leaving cancer patients to wonder whether their survival odds are hurt.

In its blog post, the White House noted that it’s now allowing Chinese imports of cisplatin. The Food and Drug Administration is also working with generic drug companies to boost production of all three drugs, but it didn’t say which companies.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Jerome Adams on the need for new antivirals for Covid
Next article： Pharmacists can make shortage drugs, but at what cost?

WSS

Hospitals owned by private equity see complications spike 25%

Researchers explore possible ties between long Covid, menopause

In Spain, a hospital brews its own CAR

STAT Summit: GSK CEO on pharma giant's new direction

How climate

Medicare drug price negotiation hasn't dried up venture capital

Wikipedia

explore

focus

Activists slam private health insurers over coverage restrictions

Hospital price transparency does save money, advocate argues

Medical leaders decry Supreme Court decision on affirmative action

STAT Readout Newsletter: Today's biggest biotech updates

Apple is now the first public company to be valued at $3 trillion

Researchers explore possible ties between long Covid, menopause

State Dept. review finds Biden bears some blame for Afghanistan failures

Why health care costs have stayed mostly flat since 2010

State Dept. review finds Biden bears some blame for Afghanistan failures

What STAT readers think about the FDA and patient advocacy

entertainment

The EU Joint Clinical Assessment needs to live up to its promise

Hospitals owned by private equity see complications spike 25%

FDA warns J&J's Abiomed: We will regulate your software

STAT Summit: How a Chicago ER doctor tackles gun violence

Can sheer will power keep patients alive in their dying hours?

Pharmacists can make shortage drugs, but at what cost?

explore

hotspot

leisure time

explore